FMC Corporation is a global agricultural sciences company dedicated to assisting growers in producing food, feed, fiber, and fuel while adapting to environmental changes. The company operates in a single business segment, focusing on the development, marketing, and sale of crop protection chemicals, including insecticides, herbicides, and fungicides, as well as biologicals, crop nutrition, and seed treatment products, collectively known as plant health . FMC's portfolio is primarily composed of insecticides and herbicides, with a smaller but growing segment of fungicides and plant health products, which are used to enhance crop yield and quality by controlling pests, weeds, and diseases . The company also invests in innovative technologies and new product formulations to maintain its competitive edge in the agrochemical industry .
- Insecticides - Develops and markets chemicals that protect crops by controlling insect pests, contributing significantly to the company's revenue.
- Herbicides - Offers solutions for weed control, helping to improve crop yield and quality by eliminating unwanted vegetation.
- Fungicides - Provides products that prevent and control fungal diseases, ensuring healthier crops and better yields.
- Plant Health Products - Includes biologicals, crop nutrition, and seed treatment products aimed at enhancing overall plant health and productivity.
You might also like
| Name | Position | External Roles | Short Bio | |
|---|---|---|---|---|
Andrew D. Sandifer Executive | Executive Vice President and CFO | Board Member at Koppers Holdings Inc.; Board Trustee at Germantown Academy | Joined FMC in 2010; held various leadership roles, including VP of Strategic Development and Treasurer. CFO since 2018, overseeing financial compliance and reporting. | |
Brian P. Angeli Executive | EVP and Chief Marketing Officer | None | Promoted to CMO on May 1, 2024; previously VP of Corporate Strategy and Precision Agriculture. Oversees portfolio management and global partnerships. | View Report → |
Jacqueline Scanlan Executive | EVP and Chief Human Resources Officer | None | Joined FMC in September 2023; previously held senior HR roles at Axalta Coating Systems and Haemonetics Corporation. | |
Michael F. Reilly Executive | EVP, General Counsel, Chief Compliance Officer, and Secretary | Board Member at First State Montessori Academy, Inc. | Joined FMC in 2013; progressed from Associate General Counsel to EVP. Oversees legal, compliance, and governance functions. | |
Ronaldo Pereira Executive | President | None | President since June 11, 2024; nearly 28 years at FMC, previously EVP and President of FMC Americas. Known for driving growth in the Americas region. | |
Thaisa Hugenneyer Executive | EVP, Operations, Supply Chain, and Procurement | None | Over 25 years at FMC; promoted to EVP in 2024, overseeing manufacturing, supply chain, and EHS. Known for strengthening supply chain resilience. | |
Vsevolod Rostovtsev Executive | EVP and Chief Technology Officer | None | Joined FMC in 2017; instrumental in R&D leadership, including the development of Dodhylex\u2122 herbicide. Co-inventor of copper-catalyzed Click Chemistry, which won the 2022 Nobel Prize. | |
Anthony DiSilvestro Board | Director | CFO at Mattel Inc. | Director since 2024; former CFO of Campbell Soup Company, with expertise in financial turnarounds and cost reduction programs. | |
C. Scott Greer Board | Lead Director | None | Director since 2002; Lead Director since 2022. Former Chairman, President, and CEO of Flowserve Corporation. | |
Dirk Kempthorne Board | Director | Board Member at Olympic Steel and Robert Half International | Director since 2009; former U.S. Secretary of the Interior and Governor of Idaho. Chairs FMC's Sustainability Committee. | |
Eduardo E. Cordeiro Board | Director | Board Member at Owens Corning; Board Member at Indicor, LLC | Director since 2011; former CFO of Cabot Corporation. Brings financial expertise and corporate strategy experience. | |
John Davidson Board | Director | Board Member at TE Connectivity Ltd. and International Flavors & Fragrances Inc.; Independent Audit Quality Committee Member at Ernst & Young, LLP | Director since 2020; extensive experience in finance and governance, including roles at TE Connectivity and Ernst & Young. | |
John M. Raines Board | Director | President of Paris Bancshares, Inc.; Board Member at TPNB Bank and Sydenstricker Nobbe Partners | Director since 2024; former President of Digital Agriculture at TELUS Corporation, with expertise in agriculture and technology. | |
K'Lynne Johnson Board | Director | Chair of the Board at Trinseo S.A.; Board Member at J.M. Huber Corporation, BlueScope Steel Limited, and Sylvatex Inc. | Director since 2013; former CEO of Elevance Renewable Sciences, with expertise in specialty chemicals and sustainability. | |
Kathy L. Fortmann Board | Director | None | Director since 2022; former CEO of ACOMO N.V. and leader of major business integrations at DuPont and IFF. | |
Margareth \u00d8vrum Board | Director | Board Member at TechnipFMC plc, Harbour Energy plc, and Transocean Ltd. | Director since 2016; former EVP at Equinor ASA with expertise in technology, sustainability, and global operations. | |
Patricia Verduin Board | Director | Board Member at Ingredion Corporation, Avient Corporation, and The Valley Hospital | Director since 2023; former Chief Technology & Science Officer at Colgate Palmolive, with expertise in R&D and sustainability. | |
Pierre R. Brondeau Board | Chairman of the Board and CEO | None | Chairman of FMC since 2010; reappointed as CEO on June 11, 2024, after previously serving as CEO from 2010 to 2020. Led FMC's transformation into a global agricultural sciences company. |
- Given that you were late in adjusting pricing in Latin America and may have lost market share to competitors, how do you plan to regain this market share while maintaining profitability in such a challenging pricing environment?
- With Rynaxypyr experiencing low single-digit global declines driven by challenges in Asia, what specific strategies are you implementing to reverse this trend and drive growth for this key product?
- You mentioned potential challenges with pricing in 2025 but have not made specific assumptions yet; how do you plan to mitigate the risk of price erosion impacting your target of 6% revenue growth next year?
- Following the bankruptcy of a large distributor in Latin America, how does this affect your distribution strategy in the region, and what measures are you taking to reduce similar risks in the future?
- With uncertainties surrounding diamide sales in 2025 due to ongoing negotiations and market conditions, how confident are you in meeting your earnings growth projections, and what contingencies are in place if diamide growth underperforms?
Research analysts who have asked questions during FMC earnings calls.
Christopher Parkinson
Wolfe Research
4 questions for FMC
Vincent Andrews
Morgan Stanley
4 questions for FMC
Aleksey Yefremov
KeyBanc Capital Markets
3 questions for FMC
Frank Mitsch
Fermium Research
3 questions for FMC
Joel Jackson
BMO Capital Markets
3 questions for FMC
Kevin McCarthy
Vertical Research Partners
3 questions for FMC
Arun Viswanathan
RBC Capital Markets
2 questions for FMC
Benjamin Theurer
Barclays Corporate & Investment Bank
2 questions for FMC
Josh Spector
UBS Group
2 questions for FMC
Joshua Spector
UBS
2 questions for FMC
Laurence Alexander
Jefferies
2 questions for FMC
Patrick Cunningham
Citigroup
2 questions for FMC
Richard Garchitorena
Wells Fargo
2 questions for FMC
Steve Byrne
Bank of America
2 questions for FMC
Duffy Fischer
Goldman Sachs
1 question for FMC
Edlain Rodriguez
Mizuho Securities
1 question for FMC
Jeff Zekauskas
JPMorgan Chase & Co.
1 question for FMC
Laurent Favre
BNP Paribas
1 question for FMC
Michael Harrison
Seaport Research Partners
1 question for FMC
Mike Harrison
Seaport Research Partners
1 question for FMC
Competitors mentioned in the company's latest 10K filing.
| Company | Description |
|---|---|
ChemChina | Owner of Syngenta Group, which includes the former Syngenta and Adama. Part of the consolidated agrochemicals industry following several mergers of leading crop protection companies. Represents approximately 73 percent of the crop protection industry’s global sales along with other major companies. |
Bayer AG | Acquired Monsanto in 2018. Part of the consolidated agrochemicals industry following several mergers of leading crop protection companies. Represents approximately 73 percent of the crop protection industry’s global sales along with other major companies. |
BASF AG | Part of the consolidated agrochemicals industry following several mergers of leading crop protection companies. Represents approximately 73 percent of the crop protection industry’s global sales along with other major companies. |
Part of the consolidated agrochemicals industry following several mergers of leading crop protection companies. Represents approximately 73 percent of the crop protection industry’s global sales along with other major companies. | |
UPL Ltd. | Part of the next group of agrochemical producers following the five major innovation companies in the industry. |
Sumitomo Chemical Company Ltd. | Part of the next group of agrochemical producers following the five major innovation companies in the industry. |
Nufarm Ltd. | Part of the next group of agrochemical producers following the five major innovation companies in the industry. |
Notable M&A activity and strategic investments in the past 3 years.
| Company | Year | Details |
|---|---|---|
BioPhero ApS | 2022 | FMC Corporation announced the acquisition of BioPhero ApS on June 29, 2022, closing the deal on July 19, 2022 for approximately $190–$200 million. The deal strategically adds BioPhero’s state-of-the-art pheromone insect control technology—including its proprietary fermentation process, extensive patent portfolio (extending through 2042), and associated know-how—to FMC’s Plant Health business with an expectation of generating around $1 billion in revenue by 2030 at above-average EBITDA margins. |
Recent press releases and 8-K filings for FMC.
- FMC sees normalized demand in crop protection, with Q3 unfolding as expected and Q4 visibility unchanged from prior guidance, noting September’s seasonality in Latin America and North America.
- The growth portfolio centers on four new active ingredients—including fluindapyr, isoflex and the $0.5 billion Salesapyr franchise—and five biologicals, with expansion paced by registration timelines.
- Core herbicide rynaxapyr will face generic entry on January 1, 2026, but FMC is equipped with competitive manufacturing costs and local market strategies to defend share.
- Regulatory outlook remains supportive: the EU may grant derogations to address product shortages, and U.S. MAHA actions pose minimal tangible risk to FMC’s operations.
- FMC delivered Q2 sales up 1% year-over-year, driven by 6% volume growth; pricing was down 3% and FX was a 1% headwind.
- Q2 adjusted EBITDA was $207 million (↑2% y/y) on lower raw material costs and improved fixed cost absorption; adjusted EPS was $0.69 (↑$0.10).
- Announced divestment of its India commercial business—India generated limited EBITDA and high working capital; expected H2 2025 India sales of ~$70 million are excluded from guidance.
- Maintained 2025 guidance ex-India: revenue down 2%, adjusted EBITDA up 1%, EPS flat; Q3 ex-India revenue down 1% (EBITDA +14%, EPS +28%), Q4 ex-India revenue up 5% (EBITDA +4%, EPS ‑3%).
- FMC management detailed its reset strategy, emphasizing operational improvements in Q1 and Q2 aimed at reestablishing robust revenue and earnings growth through a strengthened product portfolio and inventory optimization.
- New strategic partnerships were highlighted, including collaborations with Corteva and Bayer that are expected to accelerate product adoption and support future revenue expansion, despite current price pressures.
- FMC Corporation completed the sale of $750M in 8.450% Fixed-to-Fixed Reset Rate Subordinated Notes due 2055 on May 27, 2025.
- The notes carry a fixed interest rate until November 1, 2030, with subsequent 5‐year resets that include a spread of 4.366% and offer optional redemption and interest deferral provisions.
- Proceeds will be used to redeem $500M of Senior Notes due May 2026 and for general corporate purposes.
- FMC Corporation entered into an underwriting agreement to issue and sell $750 million aggregate principal amount of its 8.45% Fixed-to-Fixed Reset Rate Subordinated Notes due 2055, with the closing expected on May 27, 2025.
- The net proceeds to the Company are expected to be approximately $741 million after deducting underwriters’ discounts and offering expenses.
- FMC is executing a reset strategy by reducing inventory levels and positioning for growth in Q3 and Q4, with performance in Q1 and Q2 meeting expectations ( , ).
- The company is accelerating capacity for new technology products, including fluindapyr, Isoflex, and upcoming herbicides like Dodhylex and Rimisoxafen, with significant peak sales potential ( ).
- A recent partnership with Bayer for Isoflex and strategic adjustments in receivables, particularly in Brazil, underline FMC's focus on market-specific initiatives and operational efficiency ( , ).
- FMC emphasized channel destocking in Q1, successfully shifting significant inventory from the channel (excluding Asia) to meet targeted levels while boosting direct sales to growers.
- The company reported a 14% decline in sales YoY with pricing down 9%, impacted by lower manufacturing costs and a 4% FX headwind.
- FMC introduced a new product portfolio—with expected sales of $200M to $250M—and launched a direct sales route to Brazil aimed at driving solid second-half growth.
- The CFO highlighted a reduction in interest expense and noted negative free cash flow in Q1 due to working capital normalization, with full-year FCF guidance between $200M and $400M.
- FMC Corporation receives regulatory approval in Peru for its new Keenali herbicide powered by Dodhylex active, marking the first global registration for this breakthrough technology.
- The herbicide introduces a new mode of action—the first in over three decades—set to transform rice weed management without compromising crop safety.
- The innovation is being explored for additional crops including corn, soybean, sugarcane, and sunflower, highlighting the company's commitment to advancing agricultural solutions.